Dasatinib
- Product NDC
- 66993-237
- 11-digit product format
- 669930237
- Labeler code
- 66993
- Product ID
- 66993-237_19048218-75dd-45fc-8e6e-fc660d861fb7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Prasco Laboratories
- Application
- NDA021986
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2024-09-03
- Substance
- DASATINIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dasatinib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66993-237-30 | Dasatinib | 30 in 1 BOTTLE | TABLET | 30 | | 10 |
| 66993-237-30 | Dasatinib | 1 in 1 CARTON | TABLET | 1 | | 10 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66993-237 | DASATINIB TABLET [PRASCO LABORATORIES] | 10 | Current NDC, 2 package rows | 20240910_1931e73f-918c-4d69-9543-de9643513d05.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 66993-237-30 | 66993023730 | 1 BOTTLE in 1 CARTON (66993-237-30) / 30 TABLET in 1 BOTTLE | 1 bottle | 2024-09-03 | No | No | Historical |